Maleiimide anti-tumor phosphatase inhibitors

Details for Australian Patent Application No. 2005216200 (hide)

Owner Government of the United States of America, as represented by the Secretary Department of Health and Human Services

Inventors Michejda, Christopher J.; Kar, Siddhartha; Yao, Wei; Carr, Brian I.

Agent Pizzeys

Pub. Number AU-A-2005216200

PCT Pub. Number WO2005/081972

Priority 60/546,841 22.02.04 US

Filing date 22 February 2005

Wipo publication date 9 September 2005

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/081972 Priority application(s): WO2005/081972

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216205-Directional flow sensor inhaler

2005216196-Implant having MEMS flow module with movable, flow-controlling baffle